WallStreetZenWallStreetZen

NASDAQ: IMNM
Immunome Inc Stock Ownership - Who owns Immunome?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Immunome Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Clay B. SiegallPresident and CEO2025-12-304,729$21.15
$100.02kBuy
Isaac BarchasDirector2025-12-2211,251$22.34
$251.35kSell
Isaac BarchasDirector2025-12-22371,949$21.72
$8.08MSell
Philip TsaiChief Technical Officer2025-12-1910,000$20.49
$204.90kBuy
Clay B. SiegallPresident and CEO2025-12-197,278$20.48
$149.05kBuy
Clay B. SiegallPresident and CEO2025-12-1846,511$21.50
$999.99kBuy
Jack HigginsChief Scientific Officer2025-09-1022,000$1.35
$29.70kBuy
Jean Jacques BienaimeDirector2025-06-035,000$9.38
$46.90kBuy
Jack HigginsChief Scientific Officer2025-03-275,200$1.35
$7.02kBuy
Clay B. SiegallPresident and CEO2025-03-26137,100$7.29
$999.46kBuy

1 of 2

IMNM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IMNM insiders and whales buy or sell their stock.

IMNM Shareholders

What type of owners hold Immunome Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.24%13,056,709$321.46MInstitution
T Rowe Price Investment Management Inc9.18%8,418,163$207.26MInstitution
Blackrock Inc6.35%5,822,736$143.36MInstitution
Redmile Group LLC5.48%5,023,385$123.68MInstitution
Vanguard Group Inc5.34%4,893,626$120.48MInstitution
Point72 Asset Management LP5.26%4,824,504$118.78MInstitution
Enavate Sciences GP LLC5.20%4,768,583$117.40MInstitution
Isaac Barchas4.54%4,165,824$102.56MInsider
Ecor1 Capital LLC4.45%4,079,415$100.44MInstitution
Price T Rowe Associates Inc4.08%3,742,770$92.15MInstitution

1 of 3

IMNM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMNM92.03%7.97%Net SellingNet Selling
RARE85.64%14.36%Net SellingNet Selling
MLYS67.82%32.18%Net BuyingNet Selling
RCUS64.14%35.86%Net BuyingNet Selling
TLX0.25%0.00%
View Top Biotech Stocks

Immunome Stock Ownership FAQ

Who owns Immunome?

Immunome (NASDAQ: IMNM) is owned by 99.64% institutional shareholders, 8.63% Immunome insiders, and 0.00% retail investors. Isaac Barchas is the largest individual Immunome shareholder, owning 4.17M shares representing 4.54% of the company. Isaac Barchas's Immunome shares are currently valued at $108.89M.

If you're new to stock investing, here's how to buy Immunome stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.